+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 350 Pages
  • September 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5903249
Description Jump to:
The Global Drug Eluting Stent Market size is expected to reach $13.2 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 14,030.2 thousand units, experiencing a growth of 7.8% (2019-2022).

Non-biodegradable polymers are synthetic materials that do not break down or degrade in the body over time. Consequently, the non-biodegradable polymers segment captured $3,820.5 million revenue in the market in 2022. They are chosen for their stability and durability, which ensures that the drug release profile remains consistent over an extended period. Non-biodegradable polymers are stable and maintain their structural integrity for an extended duration, ensuring the controlled release of drugs over time. These polymers provide a more predictable and consistent drug release profile compared to biodegradable polymers, which may degrade unpredictably. Some of the factors impacting the market are expanding use of minimally invasive techniques, recent modernization of stent technology and Strict regulatory requirements on the use of drug eluting stents.



Small incisions are used in minimally invasive procedures, which have transformed the field of interventional cardiology and are changing how heart diseases are treated. Drug eluting stents offer a highly effective and minimally invasive treatment option for coronary artery disease. These stents are coated with medication to stop the re-narrowing of arteries. This has led to exponential scientific and technological advancements in minimally invasive surgery. Surgeons also had to acquire new surgical methods. These factors will boost the demand in the upcoming years. Additionally, advancements in stent technology have significantly fueled the market. These developments have enhanced stent designs, materials, and coatings, increasing DES's effectiveness, safety, and performance. The danger of inflammation and rejection has decreased by introducing biocompatible materials for stent manufacturing. These stents are designed to administer drugs as effectively as possible while reducing long-term consequences. Therefore, the market is expected to grow rapidly as technologies keep advancing.

However, Strict regulatory clearances may function as a roadblock to the expansion of the market. Numerous authorities and government organizations have established norms and recommendations for effectively and securely using stents. For instance, before approving stents, the U.S. FDA systematically examines the literature and animal pre-clinical trials. The proximal stent border experienced edge restenosis more frequently than the distal stent border, indicating that higher downstream medication concentrations may be protective. These factors can hamper the growth of the market in the future.

Additionally, the pandemic disrupted global supply chains, affecting the production and distribution of medical devices, including DES. Manufacturers faced challenges in sourcing raw materials, transporting products, and meeting demand, leading to supply shortages and delays. Keyways that COVID-19 impacted the economy directly impacted medication and vaccine demand and production, disrupting distribution networks, and an economic impact on businesses and financial sectors. Due to a rise in demand, the COVID-19 pandemic substantially affected the market for these devices. The market for drug eluting stents was impacted by the fact that patients with cardiovascular disorders encountered delays in diagnosis and treatment due to less patient traffic in hospitals and diagnostic centers. As a result, COVID-19 moderately impacted the market.

Coating type Outlook

On the basis of coating type, the market is divided into polymer-based coatings and polymer-free coatings. The polymer-based coating segment procured the largest revenue share in the market in 2022. The efficacy and adaptability of polymer-based coatings are the reason for their dominance in the market. These coatings have been carefully studied and used in developing stents, providing producers with a trustworthy option. Through continuous administration and the prevention of restenosis, the regulated drug release improves patient outcomes. Therefore, the segment will witness lucrative growth opportunities in the future.

Polymer-based Coating Outlook

The polymer-based coating segment is further subdivided into non-biodegradable polymers and biodegradable polymers. The biodegradable polymers subsegment witnessed a significant revenue share in the market in 2022. A biodegradable polymer coating holds and releases the active component; it will deteriorate and completely absorb over time (often within a year). These tools were created to eliminate the permanent polymer-induced vessel inflammation that is thought to be one of the key contributors to very late safety instances. This will boost the demand in this subsegment.

Polymer-free Coating Outlook

The polymer-free coating segment is subdivided into micro porous surface, micro structured surface, slotted tubular surface, and nanoporous surface. The micro porous surface subsegment held the maximum revenue share in the market in 2022. The production of polymer-free stents in the market primarily uses micro porous surface technology. Using microporous stent surfaces to control the drug release rate is a strategy that has lately produced some encouraging clinical outcomes. Pits on a microporous surface have dimensions in the order of micrometers in terms of their breadth, depth, and separation. Therefore, the segment will grow considerably in the coming years.

Application Outlook

Based on application, the market is bifurcated into coronary artery disease and peripheral artery disease. In 2022, the peripheral artery disease segment recorded a substantial revenue share in the market. The primary growth driver is expected to be the increasing prevalence of peripheral arterial disease (PAD) worldwide. These are widely used in treating PAD due to the growing number of patients suffering from this cardiovascular condition, especially among older adults with risk factors including diabetes and obesity. Owing to this, the segment will grow significantly in the future.

Regional Outlook

On the basis of region, the drug eluting market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. This can be attributed to the region's large patient pool for cardiovascular diseases, which can also be linked to factors like increased reliance on fast food and a sedentary lifestyle, extensive coverage by private and public health insurance providers for stent placement procedures, and an aging elderly population. One of the main factors driving the growth of the North America segment is the increasing prevalence of cardiovascular diseases like peripheral artery disease.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica

Scope of the Study

Market Segments Covered in the Report:

By Application (Volume, Thousand Units, USD Million, 2019-2030)
  • Coronary Artery Disease
  • Peripheral Artery Disease
By Coating Type (Volume, Thousand Units, USD Million, 2019-2030)
  • Polymer-based Coating
  • Non-biodegradable Polymers
  • Biodegradable Polymers
  • Polymer-free Coating
  • Micro Porous Surface
  • Micro Structured Surface
  • Slotted Tubular Surface
  • Nanoporous Surface
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic PLC
  • Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
  • Cook Medical, Inc. (Cook Group)
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd
  • Alvimedica

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Drug Eluting Stent Market, by Application
1.4.2 Global Drug Eluting Stent Market, by Coating Type
1.4.3 Global Drug Eluting Stent Market, by Geography
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Global Drug Eluting Stent Market by Application
4.1 Global Coronary Artery Disease Market by Region
4.2 Global Peripheral Artery Disease Market by Region
Chapter 5. Global Drug Eluting Stent Market by Coating Type
5.1 Global Polymer-based Coating Market by Region
5.2 Global Drug Eluting Stent Market by Polymer-based Coating Type
5.2.1 Global Non-biodegradable Polymers Market by Region
5.2.2 Global Biodegradable Polymers Market by Region
5.3 Global Polymer-free Coating Market by Region
5.4 Global Drug Eluting Stent Market by Polymer-free Coating Type
5.4.1 Global Micro Porous Surface Market by Region
5.4.2 Global Micro Structured Surface Market by Region
5.4.3 Global Slotted Tubular Surface Market by Region
5.4.4 Global Nanoporous Surface Market by Region
Chapter 6. Global Drug Eluting Stent Market by Region
6.1 North America Drug Eluting Stent Market
6.1.1 North America Drug Eluting Stent Market by Application
6.1.1.1 North America Coronary Artery Disease Market by Country
6.1.1.2 North America Peripheral Artery Disease Market by Country
6.1.2 North America Drug Eluting Stent Market by Coating Type
6.1.2.1 North America Polymer-based Coating Market by Country
6.1.2.2 North America Drug Eluting Stent Market by Polymer-based Coating Type
6.1.2.2.1 North America Non-biodegradable Polymers Market by Country
6.1.2.2.2 North America Biodegradable Polymers Market by Country
6.1.2.3 North America Polymer-free Coating Market by Country
6.1.2.4 North America Drug Eluting Stent Market by Polymer-free Coating Type
6.1.2.4.1 North America Micro Porous Surface Market by Country
6.1.2.4.2 North America Micro Structured Surface Market by Country
6.1.2.4.3 North America Slotted Tubular Surface Market by Country
6.1.2.4.4 North America Nanoporous Surface Market by Country
6.1.3 North America Drug Eluting Stent Market by Country
6.1.3.1 US Drug Eluting Stent Market
6.1.3.1.1 US Drug Eluting Stent Market by Application
6.1.3.1.2 US Drug Eluting Stent Market by Coating Type
6.1.3.2 Canada Drug Eluting Stent Market
6.1.3.2.1 Canada Drug Eluting Stent Market by Application
6.1.3.2.2 Canada Drug Eluting Stent Market by Coating Type
6.1.3.3 Mexico Drug Eluting Stent Market
6.1.3.3.1 Mexico Drug Eluting Stent Market by Application
6.1.3.3.2 Mexico Drug Eluting Stent Market by Coating Type
6.1.3.4 Rest of North America Drug Eluting Stent Market
6.1.3.4.1 Rest of North America Drug Eluting Stent Market by Application
6.1.3.4.2 Rest of North America Drug Eluting Stent Market by Coating Type
6.2 Europe Drug Eluting Stent Market
6.2.1 Europe Drug Eluting Stent Market by Application
6.2.1.1 Europe Coronary Artery Disease Market by Country
6.2.1.2 Europe Peripheral Artery Disease Market by Country
6.2.2 Europe Drug Eluting Stent Market by Coating Type
6.2.2.1 Europe Polymer-based Coating Market by Country
6.2.2.2 Europe Drug Eluting Stent Market by Polymer-based Coating Type
6.2.2.2.1 Europe Non-biodegradable Polymers Market by Country
6.2.2.2.2 Europe Biodegradable Polymers Market by Country
6.2.2.3 Europe Polymer-free Coating Market by Country
6.2.2.4 Europe Drug Eluting Stent Market by Polymer-free Coating Type
6.2.2.4.1 Europe Micro Porous Surface Market by Country
6.2.2.4.2 Europe Micro Structured Surface Market by Country
6.2.2.4.3 Europe Slotted Tubular Surface Market by Country
6.2.2.4.4 Europe Nanoporous Surface Market by Country
6.2.3 Europe Drug Eluting Stent Market by Country
6.2.3.1 Germany Drug Eluting Stent Market
6.2.3.1.1 Germany Drug Eluting Stent Market by Application
6.2.3.1.2 Germany Drug Eluting Stent Market by Coating Type
6.2.3.2 UK Drug Eluting Stent Market
6.2.3.2.1 UK Drug Eluting Stent Market by Application
6.2.3.2.2 UK Drug Eluting Stent Market by Coating Type
6.2.3.3 France Drug Eluting Stent Market
6.2.3.3.1 France Drug Eluting Stent Market by Application
6.2.3.3.2 France Drug Eluting Stent Market by Coating Type
6.2.3.4 Russia Drug Eluting Stent Market
6.2.3.4.1 Russia Drug Eluting Stent Market by Application
6.2.3.4.2 Russia Drug Eluting Stent Market by Coating Type
6.2.3.5 Spain Drug Eluting Stent Market
6.2.3.5.1 Spain Drug Eluting Stent Market by Application
6.2.3.5.2 Spain Drug Eluting Stent Market by Coating Type
6.2.3.6 Italy Drug Eluting Stent Market
6.2.3.6.1 Italy Drug Eluting Stent Market by Application
6.2.3.6.2 Italy Drug Eluting Stent Market by Coating Type
6.2.3.7 Rest of Europe Drug Eluting Stent Market
6.2.3.7.1 Rest of Europe Drug Eluting Stent Market by Application
6.2.3.7.2 Rest of Europe Drug Eluting Stent Market by Coating Type
6.3 Asia Pacific Drug Eluting Stent Market
6.3.1 Asia Pacific Drug Eluting Stent Market by Application
6.3.1.1 Asia Pacific Coronary Artery Disease Market by Country
6.3.1.2 Asia Pacific Peripheral Artery Disease Market by Country
6.3.2 Asia Pacific Drug Eluting Stent Market by Coating Type
6.3.2.1 Asia Pacific Polymer-based Coating Market by Country
6.3.2.2 Asia Pacific Drug Eluting Stent Market by Polymer-based Coating Type
6.3.2.2.1 Asia Pacific Non-biodegradable Polymers Market by Country
6.3.2.2.2 Asia Pacific Biodegradable Polymers Market by Country
6.3.2.3 Asia Pacific Polymer-free Coating Market by Country
6.3.2.4 Asia Pacific Drug Eluting Stent Market by Polymer-free Coating Type
6.3.2.4.1 Asia Pacific Micro Porous Surface Market by Country
6.3.2.4.2 Asia Pacific Micro Structured Surface Market by Country
6.3.2.4.3 Asia Pacific Slotted Tubular Surface Market by Country
6.3.2.4.4 Asia Pacific Nanoporous Surface Market by Country
6.3.3 Asia Pacific Drug Eluting Stent Market by Country
6.3.3.1 China Drug Eluting Stent Market
6.3.3.1.1 China Drug Eluting Stent Market by Application
6.3.3.1.2 China Drug Eluting Stent Market by Coating Type
6.3.3.2 Japan Drug Eluting Stent Market
6.3.3.2.1 Japan Drug Eluting Stent Market by Application
6.3.3.2.2 Japan Drug Eluting Stent Market by Coating Type
6.3.3.3 India Drug Eluting Stent Market
6.3.3.3.1 India Drug Eluting Stent Market by Application
6.3.3.3.2 India Drug Eluting Stent Market by Coating Type
6.3.3.4 South Korea Drug Eluting Stent Market
6.3.3.4.1 South Korea Drug Eluting Stent Market by Application
6.3.3.4.2 South Korea Drug Eluting Stent Market by Coating Type
6.3.3.5 Singapore Drug Eluting Stent Market
6.3.3.5.1 Singapore Drug Eluting Stent Market by Application
6.3.3.5.2 Singapore Drug Eluting Stent Market by Coating Type
6.3.3.6 Malaysia Drug Eluting Stent Market
6.3.3.6.1 Malaysia Drug Eluting Stent Market by Application
6.3.3.6.2 Malaysia Drug Eluting Stent Market by Coating Type
6.3.3.7 Rest of Asia Pacific Drug Eluting Stent Market
6.3.3.7.1 Rest of Asia Pacific Drug Eluting Stent Market by Application
6.3.3.7.2 Rest of Asia Pacific Drug Eluting Stent Market by Coating Type
6.4 LAMEA Drug Eluting Stent Market
6.4.1 LAMEA Drug Eluting Stent Market by Application
6.4.1.1 LAMEA Coronary Artery Disease Market by Country
6.4.1.2 LAMEA Peripheral Artery Disease Market by Country
6.4.2 LAMEA Drug Eluting Stent Market by Coating Type
6.4.2.1 LAMEA Polymer-based Coating Market by Country
6.4.2.2 LAMEA Drug Eluting Stent Market by Polymer-based Coating Type
6.4.2.2.1 LAMEA Non-biodegradable Polymers Market by Country
6.4.2.2.2 LAMEA Biodegradable Polymers Market by Country
6.4.2.3 LAMEA Polymer-free Coating Market by Country
6.4.2.4 LAMEA Drug Eluting Stent Market by Polymer-free Coating Type
6.4.2.4.1 LAMEA Micro Porous Surface Market by Country
6.4.2.4.2 LAMEA Micro Structured Surface Market by Country
6.4.2.4.3 LAMEA Slotted Tubular Surface Market by Country
6.4.2.4.4 LAMEA Nanoporous Surface Market by Country
6.4.3 LAMEA Drug Eluting Stent Market by Country
6.4.3.1 Brazil Drug Eluting Stent Market
6.4.3.1.1 Brazil Drug Eluting Stent Market by Application
6.4.3.1.2 Brazil Drug Eluting Stent Market by Coating Type
6.4.3.2 Argentina Drug Eluting Stent Market
6.4.3.2.1 Argentina Drug Eluting Stent Market by Application
6.4.3.2.2 Argentina Drug Eluting Stent Market by Coating Type
6.4.3.3 UAE Drug Eluting Stent Market
6.4.3.3.1 UAE Drug Eluting Stent Market by Application
6.4.3.3.2 UAE Drug Eluting Stent Market by Coating Type
6.4.3.4 Saudi Arabia Drug Eluting Stent Market
6.4.3.4.1 Saudi Arabia Drug Eluting Stent Market by Application
6.4.3.4.2 Saudi Arabia Drug Eluting Stent Market by Coating Type
6.4.3.5 South Africa Drug Eluting Stent Market
6.4.3.5.1 South Africa Drug Eluting Stent Market by Application
6.4.3.5.2 South Africa Drug Eluting Stent Market by Coating Type
6.4.3.6 Nigeria Drug Eluting Stent Market
6.4.3.6.1 Nigeria Drug Eluting Stent Market by Application
6.4.3.6.2 Nigeria Drug Eluting Stent Market by Coating Type
6.4.3.7 Rest of LAMEA Drug Eluting Stent Market
6.4.3.7.1 Rest of LAMEA Drug Eluting Stent Market by Application
6.4.3.7.2 Rest of LAMEA Drug Eluting Stent Market by Coating Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Mergers & Acquisition:
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Terumo Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations & Agreements:
7.3.6 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Trials and Approvals:
7.4.5.2 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.3 SWOT Analysis
7.6 Cook Medical, Inc. (Cook Group)
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Biotronik SE & Co. KG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Lepu Medical Technology Co., Ltd
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Alvimedica
7.10.1 Company Overview
7.10.2 SWOT Analysis
Chapter 8. Winning Imperative for Drug Eluting Stent Market

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic PLC
  • Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
  • Cook Medical, Inc. (Cook Group)
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd
  • Alvimedica

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug Eluting Stent Market by Drug Coating, Application - Global Forecast 2025-2030 - Product Image

Drug Eluting Stent Market by Drug Coating, Application - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • Global
From
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032 - Product Image

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Coating Type, Region, By Country: 2020-2030 - Product Image

Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Product Type, Coating Type, Region, By Country: 2020-2030

  • Report
  • 256 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.